HomeForex MarketInsider TradingLigand Pharmaceuticals (NASDAQ:LGND) Reaches New 52-Week High Following Analyst Upgrade Ligand Pharmaceuticals (NASDAQ:LGND) Reaches New 52-Week High Following Analyst Upgrade August 31, 2025by Trade r edarT [ad_1] Ligand Pharmaceuticals (NASDAQ:LGND) Sets New 1-Year High After Analyst Upgrade [ad_2] Source link
What’s next after a court cut Donald Trump’s $515 million fine to $0 [ad_1] NEW YORK (AP) — President Donald Trump was quick to declare “TOTAL VICTORY” after a New York appeals court…
Roth Capital Boosts InterDigital (NASDAQ:IDCC) Price Target to $350.00 [ad_1] Roth Capital lifted their target price on shares of InterDigital from $270.00 to $350.00 and gave the company a…
How major US stock indexes fared Thursday, 8/14/2025 [ad_1] Most stocks fell on Wall Street following a disappointing update on inflation. But gains for Amazon and other influential…